Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis

Journal of Clinical Gastroenterology

Volumn 44, Issue 3, 2010, Pages 229-230

  Polyzos, Stergios Alexandros ^a   Kountouras, Jannis ^a   Zavos, Christos ^a  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

BODY MASS; HUMAN; KIDNEY FUNCTION; LETTER; LINEAR REGRESSION ANALYSIS; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL;

ADIPONECTIN; DATA INTERPRETATION, STATISTICAL; FATTY LIVER; HUMANS; LINEAR MODELS; LIVER CIRRHOSIS; NONLINEAR DYNAMICS; SELECTION BIAS;

EID: 77649291610     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181b5ce68     Document Type: Letter

References (12)

1. Savvidou S, Hytiroglou P, Orfanou-Koumerkeridou H et al. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. J Clin Gastroenterol. 2009;43:765-772.
2. Bugianesi E, Pagotto U, Manini R, et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab. 2005; 90:3498-3504.
3. Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med. 2009; 72:299-314.
4. Pagano C, Soardo G, Esposito W, et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol. 2005;152:113-118.
5. Jarrar MH, Baranova A, Collantes R, et al. Adipokines and cytokines in nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2008;27:412-421.
6. Younossi ZM, Jarrar M, Nugent C, et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg. 2008;18:1430-1437.
7. Kaser S, Moschen A, Kaser A, et al. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis. J Intern Med. 2005;258:274-280.
8. Sohara N, Takagi H, Kakizaki S, et al. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels. Liver Int. 2005;25:28-32.
9. Tietge UJ, Boker KH, Manns MP, et al. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab. 2004;287:82-89.
10. Karmiris K, Koutroubakis IE, Xidakis C, et al. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:100-105.
11. Celik T, Yaman H. Elevated adiponectin levels in patients with chronic heart failure: an independent predictor of mortality or a marker of cardiac cachexia? Int J Cardiol. 2009 [Epub ahead of print].
12. Ebina K, Fukuhara A, Ando W, et al. Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clin Rheumatol. 2009;28:445-451.